Literature DB >> 18621135

The function of Stat3 in tumor cells and their microenvironment.

Bernd Groner1, Peter Lucks, Corina Borghouts.   

Abstract

Stat3 was initially recognized as a transcription factor and mediates the nuclear action of many different cytokines and growth factors. In addition to its roles in normal cell function, the inappropriate activation of Stat3 in tumor cells has attracted the attention of tumor biologists and has led to the consideration of Stat3 as a drug target. The induction of Stat3 activity under physiological circumstances is transient and many different levels of activation and deactivation have been defined. In addition to kinases and phosphatases, the SOCS proteins and the PIAS proteins have been recognized as negatively regulating components, which fine-tune the extent and the duration of Stat3 function. Its nuclear cytoplasmic shuttling is exquisitely regulated and adds to the complexity of Stat3 action. Newly discovered associations with cytoplasmic molecules suggest functions outside the conventional transcriptional regulation context. High molecular weight transcription complexes suggest that Stat3 might assume roles in transcriptional induction as well as in transcriptional suppression. The aberrant activation in tumor cells and the central function of Stat3 in the communication between cells of the immune system and tumor cells are of great interest for translational research projects and innovative drug development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621135     DOI: 10.1016/j.semcdb.2008.06.005

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  64 in total

1.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

Authors:  Xueliang Gao; Haizhen Wang; Jenny J Yang; Xiaowei Liu; Zhi-Ren Liu
Journal:  Mol Cell       Date:  2012-02-02       Impact factor: 17.970

Review 2.  miRNAs stem cell reprogramming for neuronal induction and differentiation.

Authors:  Claire Perruisseau-Carrier; Marcin Jurga; Nico Forraz; Colin P McGuckin
Journal:  Mol Neurobiol       Date:  2011-03-29       Impact factor: 5.590

3.  Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells.

Authors:  Emarndeena H Cheteh; Victoria Sarne; Sophia Ceder; Julie Bianchi; Martin Augsten; Helene Rundqvist; Lars Egevad; Arne Östman; Klas G Wiman
Journal:  Cell Death Discov       Date:  2020-06-02

Review 4.  Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.

Authors:  Bernd Groner; Axel Weber; Laura Mack
Journal:  Bioengineered       Date:  2012-07-24       Impact factor: 3.269

5.  Correlation analysis of STAT3 and VEGF expression and eosinophil infiltration in nasal polyps.

Authors:  Qingsong Cao; Tao Zhang; Jie Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-25       Impact factor: 2.503

Review 6.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

Review 7.  Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Transl Lung Cancer Res       Date:  2017-08

8.  Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.

Authors:  Gregory B Lesinski; Jason M Zimmerer; Melanie Kreiner; John Trefry; Matthew A Bill; Gregory S Young; Brian Becknell; William E Carson
Journal:  BMC Cancer       Date:  2010-04-14       Impact factor: 4.430

9.  Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

Authors:  Andrew Jarnicki; Tracy Putoczki; Matthias Ernst
Journal:  Cell Div       Date:  2010-05-17       Impact factor: 5.130

10.  STAT3 silencing inhibits glioma single cell infiltration and tumor growth.

Authors:  Maike Priester; Ekaterini Copanaki; Vida Vafaizadeh; Sandra Hensel; Christian Bernreuther; Markus Glatzel; Volker Seifert; Bernd Groner; Donat Kögel; Jakob Weissenberger
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.